Frontiers in Pharmacology | Drugs Outcomes Research and Policies

Original Research

Published on 20 Feb 2024

The characteristics and operations of “online pharmacies” investigated in relation to medicines popularised during the coronavirus pandemic: a cross-sectional study

in Drugs Outcomes Research and Policies

Oria Jason Oriakhi
Hamzeh Almomani
Nilesh Patel
Parastou Donyai

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1346604

6,624 views
1 citation

Original Research

Published on 16 Feb 2024

Evaluation of medication safety assessment tools for pharmacist-led medication reviews: the Eastern European pilot project

in Drugs Outcomes Research and Policies

Anita Tuula
Piotr Merks
Magdalena Waszyk-Nowaczyk
Mariola Drozd
Galina Petrova
Reka Viola
Veera Bobrova
Michael Scott
Marje Oona
Daisy Volmer

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1348400

3,280 views
2 citations

Original Research

Published on 14 Feb 2024

The impact of level of documentation on the accessibility and affordability of new drugs in Norway

in Drugs Outcomes Research and Policies

Gro Live Fagereng
Anne Marit Morvik
Sara Reinvik Ulimoen
Anne Marthe Ringerud
Iselin Dahlen Syversen
Erik Sagdahl

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1338541

2,737 views
1 citation

Original Research

Published on 14 Feb 2024

Real-world data for the availability of pediatric medicines in Chinese hospitals: a multi-center survey and analysis

in Drugs Outcomes Research and Policies

Wen-Yi Ruan
Hui-Ying Chen
He-Ping Cai
Xiao-Ling Wang
Zhi-Gang Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1283068

1,181 views
2 citations

Review

Published on 13 Feb 2024

What influences consumers’ online medication purchase intentions and behavior? A scoping review

in Drugs Outcomes Research and Policies

Yam B. Limbu
Bruce A. Huhmann

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1356059

10,706 views
15 citations

Review

Published on 13 Feb 2024

Progress in the study of reproductive toxicity of platinum-based antitumor drugs and their means of prevention

in Drugs Outcomes Research and Policies

Zhan Jin
Liu Zhao-Xia
Peng Fan-Ke
Zhang Wen-Juan
Wei Min-Li
Zeng Han-Yi

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1327502

2,818 views
6 citations

Original Research

Published on 08 Feb 2024

Impacts of national volume-based drug procurement policy on the utilization and costs of antihypertensive drugs in a Chinese medicine hospital: an interrupted time series analysis of 5138 patients

in Drugs Outcomes Research and Policies

Lili Shang
Yan Cheng
Jifang Zhou
Yuqing Bao
Desong Kong
Ruijian Huang
Yanfei Chen
Hao Wang
Ning Gu
Aixia Ma

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1302154

2,710 views
2 citations

Review

Published on 08 Feb 2024

Effectiveness of perindopril/amlodipine fixed-dose combination in the treatment of hypertension: a systematic review

in Drugs Outcomes Research and Policies

Truong Van Dat
Vo Linh Tu
Le Nguyen Anh Thu
Nguyen Nhat Anh Quang
Van Binh
Nguyen Thi Quynh Nga
Duong Hoang Loc
Tran Thi Hong Nguyen
Dao Ngoc Hien Tam
Hong-Han Huynh

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1156655

9,167 views
3 citations

Perspective

Published on 07 Feb 2024

Enhancing the clinical research workforce: a collaborative approach with human resources

in Drugs Outcomes Research and Policies

Denise C. Snyder
Heather Gaudaur
Mark Marchant
Laura Viera
Andrea McCubbin
William Verble
Angela Mendell
Christine Gilliam

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1295155

2,936 views
3 citations

Review

Published on 07 Feb 2024

Esketamine combined with sufentanil versus sufentanil in patient-controlled intravenous analgesia: a meta-analysis

in Drugs Outcomes Research and Policies

Manman Yao
Baoxia Fang
Jinguo Yang
Peng Chen
Fuchao Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1247646

3,737 views
7 citations

Original Research

Published on 05 Feb 2024

Cost-effectiveness of tumor-treating fields plus standard therapy for advanced non-small cell lung cancer progressed after platinum-based therapy in the United States

in Drugs Outcomes Research and Policies

Wentao Tian
Jiaoyang Ning
Liu Chen
Yu Zeng
Yin Shi
Gang Xiao
Shuangshuang He
Guilong Tanzhu
Rongrong Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1333128

3,571 views
4 citations

Original Research

Published on 31 Jan 2024

A real-world disproportionality analysis of mesalazine data mining of the public version of FDA adverse event reporting system

in Drugs Outcomes Research and Policies

Mingdi Liu
Liting Gu
Yuning Zhang
Honglan Zhou
Yishu Wang
Zhi-Xiang Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1290975

3,537 views
10 citations

Original Research

Published on 29 Jan 2024

Impact of a pharmacist-led educational intervention on knowledge, attitude, and practice toward the rational use of antibiotics among healthcare workers in a secondary care hospital in Punjab, Pakistan

in Drugs Outcomes Research and Policies

Shairyar Afzal
Farman Ullah Khan
Muhammad Tahir Aqeel
Matti Ullah
Mishal Bajwa
Masoom Akhtar
Muhammad Majid

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1327576

3,543 views
11 citations

Original Research

Published on 29 Jan 2024

Real world drug treatment models for pregnancy complicated with urinary tract infection in China from 2018 to 2022: a cross-section analysis

in Drugs Outcomes Research and Policies

Jing Jin
Changyan Li
Yuqing He
Jiaqian Pan
JiaLei Zhu
Jing Tang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1349121

2,937 views
2 citations

Original Research

Published on 29 Jan 2024

Ethics of access to newly approved expensive medical treatments: multi-stakeholder dialogues in a publicly funded healthcare system

in Drugs Outcomes Research and Policies

Charlotte H. C. Bomhof
Jilles Smids
Sybren Sybesma
Maartje Schermer
Eline M. Bunnik

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1265029

2,815 views
1 citation

Original Research

Published on 26 Jan 2024

Applying the estimand and target trial frameworks to external control analyses using observational data: a case study in the solid tumor setting

in Drugs Outcomes Research and Policies

Letizia Polito
Qixing Liang
Navdeep Pal
Philani Mpofu
Ahmed Sawas
Olivier Humblet
Kaspar Rufibach
Dominik Heinzmann

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1223858

5,458 views
3 citations